#Global Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast

[harshnews]

Plant Genomics Market Size, Share, Trends, Growth Opportunities and Competitive Outlook

"Global Plant Genomics Market - Industry Trends and Forecast to 2029

Global Plant Genomics Market, By Type (Molecular Engineering, Genetic Engineering and Genome Editing and Others), Trait (Yield Improvement, Disease Resistance, Herbicide Tolerance and Others), Objective (DNA Extraction & Purification, DNA/RNA Sequencing, Genotyping, Gene Expression Profiling, Marker-Assisted Selection, GMO-trait Purity Testing, Hybrid Purity Testing, Targeted Resequencing, DNA Parentage Testing, QTL Mapping,  and Genetic Disease), Application (Cereals & Grains, Oilseeds & Pulses, Fruits & Vegetables, Sugar Crops, Ornamentals and Alfalfa), Country (U.S., Canada, Mexico, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, UAE, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2029

Access Full 350 Pages PDF Report @

**Segments**

- On the basis of application, the plant genomics market is segmented into transcriptomics, proteomics, metabolomics, and others. Transcriptomics involves the study of RNA molecules to understand gene expression levels, while proteomics focuses on studying proteins to unravel their functions. Metabolomics analyzes the metabolites within a cell or organism to gain insights into metabolic pathways and biochemical processes.

- In terms of technique, the market can be categorized into molecular markers, DNA sequencing, gene expression analysis, and other techniques. Molecular markers such as SSRs (Simple Sequence Repeats) and SNPs (Single Nucleotide Polymorphisms) are crucial for genetic mapping and marker-assisted breeding. DNA sequencing plays a fundamental role in deciphering plant genomes, while gene expression analysis helps in understanding how genes are regulated and activated.

- Based on end-users, the plant genomics market is segmented into academic research institutes, biotechnology companies, pharmaceutical companies, and others. Academic research institutes are at the forefront of exploring new frontiers in plant genomics, while biotechnology and pharmaceutical companies leverage genomics data for developing genetically modified crops, novel therapeutics, and plant-based products.

**Market Players**

- Some prominent players in the plant genomics market include Illumina Inc., Thermo Fisher Scientific Inc., Eurofins Scientific, Qiagen, Agilent Technologies, Biomatters Ltd., KeyGene, Danaher, LC Sciences, and PerkinElmer. These companies are heavily invested in developing cutting-edge genomics technologies, such as next-generation sequencing platforms, bioinformatics tools, and molecular markers for precision breeding programs. Illumina, in particular, is known for its high-throughput sequencing systems that have revolutionized genomics research across various sectors.

- Additionally, academic research institutions like the Boyce Thompson Institute, Max Planck Institute for Plant Breeding Research, and John Innes Centre play a significant role in advancing plant genomics through collaborative research, knowledge sharing, and technology transfer. ThesePlant genomics market is experiencing significant growth due to the increasing demand for sustainable agriculture practices, rising food security concerns, and advancements in genomic technologies. The application segment of the market plays a crucial role in understanding the complexities of plant biology. Transcriptomics, proteomics, and metabolomics provide valuable insights into gene expression, protein functions, and metabolic pathways, respectively, enabling researchers to develop crop varieties with desirable traits such as higher yield, stress resistance, and nutritional content. As the understanding of plant genomes deepens, the potential for targeted genetic modifications and precision breeding increases, driving the growth of the plant genomics market.

Technological advancements have propelled the plant genomics market forward, with molecular markers, DNA sequencing, and gene expression analysis being key techniques for studying plant genomes. Molecular markers like SSRs and SNPs are essential for genetic mapping and marker-assisted breeding programs, leading to the development of improved crop varieties with increased productivity and resilience to biotic and abiotic stresses. DNA sequencing has revolutionized the field of genomics by enabling the rapid and cost-effective decoding of plant genomes, facilitating genome-wide association studies and comparative genomics analyses. Gene expression analysis complements sequencing data by providing insights into how genes are regulated and function under different environmental conditions, offering valuable information for crop improvement strategies and trait selection.

The plant genomics market is driven by a diverse set of end-users, including academic research institutes, biotechnology companies, and pharmaceutical companies. Academic institutions play a crucial role in fundamental research and discovery, pushing the boundaries of plant genomics through collaboration and knowledge sharing. Biotechnology and pharmaceutical companies leverage genomics data to develop genetically modified crops, biopharmaceuticals, and plant-based products with enhanced traits and functionalities. These industry players drive innovation in plant genomics by translating research findings into practical applications that address global challenges such as food insecurity, climate change, and sustainable agriculture practices.

Prominent market players such as Illumina Inc., Thermo Fisher Scientific Inc., and Qiagen are at the**Segments:** - Molecular Engineering - Genetic Engineering and Genome Editing - Others

**Trait:** - Yield Improvement - Disease Resistance - Herbicide Tolerance - Others

**Objective:** - DNA Extraction & Purification - DNA/RNA Sequencing - Genotyping - Gene Expression Profiling - Marker-Assisted Selection - GMO-trait Purity Testing - Hybrid Purity Testing - Targeted Resequencing - DNA Parentage Testing - QTL Mapping - Genetic Disease

**Application:** - Cereals & Grains - Oilseeds & Pulses - Fruits & Vegetables - Sugar Crops - Ornamentals - Alfalfa

Global Plant Genomics Market is witnessing remarkable growth driven by advancements in genomic technologies and the increasing demand for sustainable agriculture solutions. The market segments based on molecular engineering, genetic engineering, and genome editing are pivotal in shaping the future of plant genomics research and application. Traits like yield improvement, disease resistance, and herbicide tolerance are key focus areas for developing genetically modified crops with enhanced characteristics. Objectives such as DNA extraction, genotyping, and gene expression profiling are instrumental in unraveling the genetic makeup of plants for targeted breeding and trait selection, contributing to agricultural innovation and productivity.

The application of plant genomics spans across various crops such as cereals, oilseeds, fruits, and vegetables, addressing specific needs in different agricultural sectors. The global market analysis

Major Points Covered in TOC:

Plant Genomics Market Overview: It incorporates six sections, research scope, significant makers covered, market fragments by type, Plant Genomics Market portions by application, study goals, and years considered.

Plant Genomics Market Landscape: Here, the opposition in the Worldwide Plant Genomics Market is dissected, by value, income, deals, and piece of the pie by organization, market rate, cutthroat circumstances Landscape, and most recent patterns, consolidation, development, obtaining, and portions of the overall industry of top organizations.

Plant Genomics Profiles of Manufacturers: Here, driving players of the worldwide Plant Genomics Market are considered dependent on deals region, key items, net edge, income, cost, and creation.

Plant Genomics Market Status and Outlook by Region: In this segment, the report examines about net edge, deals, income, creation, portion of the overall industry, CAGR, and market size by locale. Here, the worldwide Plant Genomics Market is profoundly examined based on areas and nations like North America, Europe, China, India, Japan, and the MEA.

Plant Genomics Application or End User: This segment of the exploration study shows how extraordinary end-client/application sections add to the worldwide Plant Genomics Market.

Plant Genomics Market Forecast: Production Side: In this piece of the report, the creators have zeroed in on creation and creation esteem conjecture, key makers gauge, and creation and creation esteem estimate by type.

Keyword: Research Findings and Conclusion: This is one of the last segments of the report where the discoveries of the investigators and the finish of the exploration study are given.

Browse Trending Reports:

Forage Harvester Market Calcify Uremic Arteriolopathy Drug Market Alexipharmic Drugs Market Resectoscope Market Coal To Liquid Market Air Electrode Battery Market Power Sports Batteries Market Body Scrub Market Cataplexy Treatment Market Alveolar Capillary Dysplasia Treatment Market Quantum Computing Market Control Valves Market Hemodialysis Peritoneal Dialysis Market Breathable Films Market Utility Locator Market Food Humectants Market Electronic Safety System Market Reporter Gene Assay Market Security Assertion Markup Language Saml Authentication Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC : +653 1251 975

Email: corporatesales@databridgemarketresearch.com"

[adityarana1687-blog]

Genotyping Market To Surge Beyond $46.5 Billion By 2030

The global genotyping market size is expected to reach USD 46.5 billion by 2030, expanding at a CAGR of 15.6%, according to a new report by Grand View Research Inc. Factors such as the rising prevalence of genetic diseases, rising awareness and research for personalized medicine, and increasing R&D funding for genomics research is expected to contribute to this growth.

Governments in multiple countries are taking various initiatives to provide support and funding to research organizations for personalized medicine, and genotyping research is anticipated to drive the market. For instance, in August 2019, NIH funded USD 4.6 million initial grants to Color, a health technology company, for precision medicine initiatives and development. Similarly, in 2018, the Government of Australia launched the Australian Genomics Health Futures Mission initiative. The government will provide USD 500 million over a period of 10 years for this mission, and the funding will be sourced from Medical Research Future Fund to improve the testing and diagnosis of genetic diseases and for the development of personalized medicine.

An increase in the prevalence of diseases such as cancer, Alzheimer’s disease, and Parkinson’s disease is another factor that is anticipated to drive demand for genotyping-based diagnostic testing. For instance, Roche has products such as Cobas HCV GT products for cervical cancer diagnosis. Additionally, 23&Me provides genetic testing for medical conditions, such as Parkinson's disease and Alzheimer’s disease.

Failed clinical trials cost companies millions of dollars and therefore companies group patients according to their genotypes. Single Nucleotide Polymorphisms (SNP) based genotyping is increasingly being used in pharmacogenomics to study the effect of genetic variations on the difference in response to therapeutics. Genotyping-based treatment administration also helps in overall cost savings.

The COVID-19 pandemic increased the demand for genotyping-based research activities for the development of COVID diagnostics, vaccines, and therapeutics. Many companies, including Qiagen and Thermo Fisher Scientific, have now launched COVID-19 genotyping kits as a result of the growing demand.

Key players leverage strategic partnerships and new product launches to increase their product offerings. For instance, in January 2020, Illumina and Roche entered into a partnership for improving patient access to oncology genomic testing by assay development. Similarly, in June 2021, the Center for Aquaculture Technologies collaborated with Neogen Corporation to provide high-quality genotyping services tailored to aquaculture producers’ specific demands.

Request a free sample copy or view report summary: Genotyping Market Report

Genotyping Market Report Highlights

The reagents & kit segment accounted for the largest share of 61.6% in the market in 2021. This is attributed to increased demand for genetic testing, increased R&D spending, and increased genotyping testing volumes

PCR segment dominated the market in 2021, whereas sequencing is expected to expand at the highest CAGR during the forecast period. This is due to advantages of the technique, such as low cost per sample, reduced bias as compared to arrays, comparative analysis across samples with no reference genome

Pharmacogenomics is estimated to be the fastest-growing application segment during the forecast period due to increased usage of genotyping in drug development to reduce attrition of products in clinical development

North America accounted for the largest market share in 2021, owing to proactive government measures, high disease prevalence, technological advancements, and advanced healthcare infrastructure

Genotyping Market Segmentation

Grand View Research has segmented the global genotyping market based on product, technology, application, end-use, and region:

Genotyping Product Outlook (Revenue, USD Million, 2018 - 2030)

Instruments

Sequencers & Amplifiers

Analyzers

Reagents and kits

Services

Genotyping Services

Genotyping Technology Outlook (Revenue, USD Million, 2018 - 2030)

PCR

Real-time PCR

Digital PCR

Capillary Electrophoresis

Amplified Fragment Length Polymorphism

Restriction Fragment Length Polymorphism

Single-Strand Conformation Polymorphism

Microarrays

DNA Microarrays

Peptide Microarrays

Others

Sequencing

Next Generation Sequencing

Pyro Sequencing

Sanger Sequencing

Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-TOF) Mass Spectroscopy

Others

Genotyping Application Outlook (Revenue, USD Million, 2018 – 2030)

Diagnostics

Drug Discovery and Development

Personalized Medicine

Academic Research

Agriculture

Others

Genotyping End-Use Outlook (Revenue, USD Million, 2018 – 2030)

Pharmaceutical And Biopharmaceutical Companies

Diagnostics And Research Laboratories

Academic Institutes

Others

Genotyping Regional Outlook, by Revenue (USD Million, 2018 - 2030)

North America

U.S.

Canada

Europe

Germany

U.K.

France

Italy

Spain

Asia Pacific

China

India

Japan

Australia

South Korea

Latin America

Brazil

Mexico

Argentina

MEA

South Africa

Saudi Arabia

UAE

List of key players in the Genotyping Market

Illumina Inc.

Thermo Fisher Scientific Inc.

Qiagen Inc.

F. Hoffmann-La Roche Ltd.

Fluidigm Corporation

Danaher Corporation

Agilent Technologies

Eurofins Scientific Inc.

GE Healthcare Inc.

Bio-Rad Laboratories Inc.

[industryforecastnews]

Genotyping Market Size Worth $37.1 Billion By 2024 | Global and Regional Forecast | Grand View Research, Inc.

The global genotyping market size is expected to reach USD 37.1 billion by 2024 according to a new report by Grand View Research, Inc. The increasing demand for genotyping tests to evaluate drug efficacy and safety is one of the major drivers for the genotyping market. Genotyping tests are widely used in selecting a highly responsive, patient population subset against a specific drug candidate before initiating clinical trials. The rising need for affordable genotyping services coupled with the high demand for personalized medicines is also expected to propel the market growth. 

Major pharmaceutical companies are collaborating with diagnostic manufacturers for the development of novel biomarker-based therapeutics. Significant opportunities for the growth of this market are anticipated due to the above-mentioned collaborative initiatives. 

The increasing awareness for prenatal genetic testing pertaining to early detection of chromosomal abnormalities in the high-risk population, the introduction of technological advancements, and the increasing R&D funding are the other factors accentuating the market growth over the forecast period. 

The rising prevalence of genetic diseases, such as Parkinson’s, turner syndrome, and Alzheimer’s is the high impact rendering driver for the market growth. Genotyping facilitates rapid sequencing and the early diagnosis of these aforementioned diseases further aid healthcare professionals to decide on probable treatment options.

Companies are undertaking R&D initiatives for the development of advanced products to cater to the increasing demands of the target population. For instance, in 2014, Fluidigm Corporation introduced the Juno 96.96 Genotyping IFC that analyzes a large number of DNA samples for Single Nucleotide Polymorphisms (SNPs) in a short time span.

Browse Full Report (Tables & Figures) @ https://www.grandviewresearch.com/industry-analysis/genotyping-market

Contact Us:

Grand View Research, Inc. 201 Spear Street 1100, San Francisco, CA 94105 United States

Phone: 

1-415-349-0058

Toll Free: 

1-888-202-9519

[marketreportoutlook]

Single Nucleotide Polymorphism Genotyping Market Size, Share, Growth Opportunity and Trends by Growing CAGR till 2026

The global Single Nucleotide Polymorphism Genotyping Market research report 2021 available on DecisionDatabases covers top company players in various countries along with analyzing the market trends and growth rate. Segment analysis by types and application helps in bifurcating the Single Nucleotide Polymorphism Genotyping Market and understand each product type. This report provides information on various market factors such as market size, share, manufacturer's data, growth, and forecast till 2026

The key market players for the global Single Nucleotide Polymorphism Genotyping market are listed below:

Illumina

Luminex Corporation

Agilent Technologies

Affymetrix

Qiagen

Applied Biosystems

Bio-rad

Roche

Beckman Coulter

Enzo Life Sciences

Douglas Scientific

HuaGene Biotech

Sequenom

Benegene

BGI

GenScript

Ocimum Biosolutions

Generay Biotech

Beijing Sunbiotech

Others

Click here to get a FREE Sample Copy of the Single Nucleotide Polymorphism Genotyping Market Research Report @ https://www.decisiondatabases.com/contact/download-sample-26639

The Global Single Nucleotide Polymorphism (SNP) Genotyping Market Report is equipped with market data from 2016 to 2026. The report gives a market overview covering key drivers and risk factors. The report is bifurcated by top global manufactures mentioning sales, revenue, and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2021 to 2026. The detailed sales channel is also covered in the study.

COVID-19 Impact Analysis on Single Nucleotide Polymorphism Genotyping Market

The global pandemic COVID-19 has affected the Single Nucleotide Polymorphism (SNP) Genotyping market directly or indirectly. This study covers a separate section giving an explicitly clear understanding of the aftereffects of this pandemic. The detailed study highlights the probable outcomes of this global crisis on the Single Nucleotide Polymorphism (SNP) Genotyping industry. The impact study on production, supply-demand, and sales provides a holistic approach to the future.

Do You Have Any Query Or Report Customization? Ask Our Market Expert @ https://www.decisiondatabases.com/contact/ask-questions-26639

Why Purchase this Report?

A robust research methodology has been followed to collect data for the report. Data, thus collected passes through multiple quality checks to ensure the best quality is served.

The report gives a holistic view of the competitive scenario of the Single Nucleotide Polymorphism (SNP) Genotyping market

The latest product launches along with technological changes and development are covered in the report.

The data analysis in the report helps in understanding the anticipated Single Nucleotide Polymorphism (SNP) Genotyping market dynamics from 2021 to 2026.

DecisionDatabases has a vast repository of data, therefore, we can accommodate customized requirements also.

The graphs, tables and pie charts, and info-graphics covered in the report will help in a better understanding of the report.

The market drivers, restraints, upcoming opportunities, and anticipated restraints cited in the report will assist in making an informed decision.

To better understand the market scenario, the Single Nucleotide Polymorphism (SNP) Genotyping market is segmented as below:

By Types:

Transversion

Transition

By Applications:

Diagnostics

Animal

Plant

Research

Others

By Regions:

North America (U.S., Canada, Mexico)

Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)

Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)

Latin America (Brazil, Rest of L.A.)

The Middle East and Africa (Turkey, GCC, Rest of Middle East)

The content of the study subjects includes a total of 14 chapters:

Chapter 1: To describe Single Nucleotide Polymorphism (SNP) Genotyping product scope, market overview, market opportunities, market driving force, and market risks. Chapter 2: To profile the top manufacturers of Single Nucleotide Polymorphism (SNP) Genotyping, with price, sales, revenue, and global market share of Single Nucleotide Polymorphism (SNP) Genotyping in 2018 and 2019. Chapter 3: The Single Nucleotide Polymorphism (SNP) Genotyping competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4: The Single Nucleotide Polymorphism (SNP) Genotyping breakdown data are shown at the regional level, to show the sales, revenue, and growth by region, from 2015 to 2020. Chapter 5 and 6: To segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020. Chapter 7, 8, 9, 10 & 11: To break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2016 to 2021 and Single Nucleotide Polymorphism (SNP) Genotyping market forecast, by regions, type, and application, with sales and revenue, from 2021 to 2026. Chapter 12, 13 & 14: To describe Single Nucleotide Polymorphism (SNP) Genotyping sales channel, distributors, customers, research findings and conclusion, appendix, and data source.

Directly Purchase the Complete Global Single Nucleotide Polymorphism Genotyping Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-26639

About Us:

DecisionDatabases.com is a global business research report provider, enriching decision-makers, and strategists with qualitative statistics. DecisionDatabases.com is proficient in providing syndicated research reports, customized research reports, company profiles, and industry databases across multiple domains. Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors. We provide intellectual, precise, and meaningful data at a lightning speed.

For more details: DecisionDatabases.com E-Mail: sales@decisiondatabases.com Phone: +91 90 28 057900 Web: https://www.decisiondatabases.com/

[the-madhuri]

Global Biochip Scanner Market-Industry Analysis and Forecast (2019-2027) – By Type, End User, and Region.

Global biochip scanner market size was US$ XX Bn in 2019 and is expected to reach US$ XX Bn by 2027, at a CAGR of ~18% during the forecast period.

Global Biochip Scanner Market

The report study has analyzed the revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers, and market disrupters in the report, and the same is reflected in our analysis.

Market Definition

Biochips are miniature version of the laboratories and are the most significant part of molecular biology. Biochips are generally used to perform thousands or hundreds of biochemical reactions at the same time. A biochip scanner is a device that is used to discover and obtain fluorescence signal data from biochips or biological microchips and these devices consist of a laser to emit a laser beam and scan the particular rows of the biochips.

Market Dynamics

A biochip scanner market has witnessed an ample growth from the past few years. The growth of the biochip scanner market is primarily driven by its growing significance in various biomedical applications. An increasing requirement to reduce turnaround time, rising demand of biochip scanners for researches and diagnostics activities to perform clinical tests, growing technological advancements and rising applications of biochips, ongoing research and development activities in large-scale genomic and proteomic field and advances in nanotechnology are expected to improve growth of the market during the forecast period.

However, high cost of biochip scanners, risks of hazardous problems of individual privacy and high complexity of biological systems are major restraining factors that could hamper the growth of the market.

Global Biochip Scanner Market: Segmentation Analysis

By type, the DNA chip segment dominated the market in 2019 and is projected to witness fast growth at a CAGR of XX% during the forecast period. Increasing investments in research activities and rising demand for next-generation and advanced genetic disorder diagnosis and detection tools are attributed to the growth of the market. A rising adoption of DNA chips in applications such as gene expression profiling, to identify novel drugs, to discover the dissimilarities in gene expression levels in cells and to detect the mutations in specific genes is expected to improve growth of the market during the forecast period.

Global Biochip Scanner Market: Regional Analysis

Region-wise, North America held the largest market share in 2019 and is expected to maintain its dominance at a CAGR of XX% during the forecast period. The US and Canada are the major key contributors behind the growth of the market. The growth is attributed to the growing technological advancements in the biomedical field across the region.

Growing adoption of biochip scanners in research laboratories and increasing use of biochip scanning technology in drug development, clinical research, toxicology studies, diagnostics and in various clinical trials is driving the growth of the market in the NA region.

The objective of the report is to present a comprehensive analysis of the Global Biochip Scanner Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Biochip Scanner Market dynamics, structure by analyzing the market segments and projects the Global Biochip Scanner Market. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Biochip Scanner Market make the report investor’s guide.

For more information visit the link given belowhttps://www.maximizemarketresearch.com/market-report/global-biochip-scanner-market/70484/

The Scope of Global Biochip Scanner Market

Global Biochip Scanner Market, By Type

• DNA Chips • Lab-On-A-Chip • Protein Chips • Cancer Diagnosis and Treatment • Gene Expression • Single Nucleotide Polymorphism (SNP) Genotyping • Genomics • Drug Discovery • Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) Global Biochip Scanner Market, By End User

• Biotechnology & Pharmaceutical Companies • Hospitals & Diagnostics Centers • Academic & Research Institutes Global Biochip Scanner Market, By Region

• North America  US  Canada • Europe  UK  France  Germany  Italy  Spain  Norway  Russia • Asia Pacific  China  India  Japan  South Korea  Australia  Malaysia  Indonesia • South America  Brazil  Mexico  Argentina • Middle East and Africa Global Biochip Scanner Market, Key Players

• Agilent Technologies, Inc • Bio-Rad Laboratories, Inc • Cepheid Inc • Fluidigm Corporation • GE Healthcare • Hoffman-La-Roche Ltd • Illumina, Inc • Ocimum Biosolutions Ltd • PerkinElmer, Inc • Takara Bio Inc • Thermo Fisher Scientific Inc • Merck Millipore • Sigma-Aldrich Corporation • Abbott Laboratories • XX • XX

This report is submitted by Maximize market Research Company

Customization of the report:

Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Lumawant Godage

Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Address: Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk,Pune, Maharashtra 411051, India.

Contact: +919607195908

[priyacmi]

DNA/Gene Microarray Market, By Type (oDNA, cDNA), By Application (Genomics, Proteomics, Agricultural biology, Environment, Drug R&D, Gene expression and SNP analysis, Cancer/oncology, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

A DNA microarray or chip is a semiconductor surface on which sequences of many varied genes are bonded to probes. DNA microarrays are used to quantify expression levels of numbers of genes simultaneously or to genotype multiple regions of a genome. The approach finds application in drug R&D, clinical diagnosis, agriculture, environment control, and other sectors.

The global DNA/gene microarray market is estimated to account for US$ 3,018.3 Mn in terms of value in 2020 and is expected to reach US$ 7,693.0 Mn by the end of 2027.

Global DNA/Gene Microarray Market: Drivers

Increasing adoption of genetic testing is expected to propel growth of the global DNA/gene microarray market over the forecast period. For instance, in April 2020, Axovant Gene Therapies collaborated with Invitae Corporation, a provider of advanced medical genetics, to offer free genetic testing in the U.S. and Canada for pediatric lysosomal storage disease.

Moreover, development of novel microarray technology is also expected to fuel growth of the global DNA/gene microarray market over the forecast period. For instance, in December 2019, PathogenDx, Inc. was awarded two US Patents for Tandem PCR + Microarray Hybridisation technology.

North America held dominant position in the global DNA/gene microarray market in 2019, accounting for 34.1% share in terms of value, followed by Europe and Asia Pacific, respectively

Figure 1. Global DNA/Gene Microarray Market Share (%), by Value, by Region, 2019

Global DNA/Gene Microarray Market: Restraints

Lack of technically trained resources, especially in emerging economies, is expected to hinder growth of the global DNA/gene microarray market. Technologically versed and skilled resources are a prerequisite for using DNA/gene microarrays and sequencers. Shortage of such trained personnel is expected to limit market growth.

Moreover, chip compatibility issues are also expected to limit the market growth. A company’s microarray is compatible only with its scanner, fluidics station, autoloader, and operating software alone wherein the manufacturers strive to maintain proprietary rights by following a closed system. Such system specificity principle is believed to create entry barriers for upcoming and new players in the market.

Global DNA/Gene Microarray Market: Opportunities 

R&D in cancer is expected to offer lucrative growth opportunities for players in the market. For instance, in April 2020, researchers from National Defense Medical Center, Taiwan, reported use of DNA microarray gene expression profiles in a research to assess the immunofunctionomes of ovarian clear cell carcinoma in early and advanced stages.

Moreover, increasing prevalence of cancer is also expected to aid in growth of the market. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.

The global DNA/gene microarray market was valued at US$ 2,640.7 Mn in 2019 and is forecast to reach a value of US$ 7,693.0 Mn by 2027 at a CAGR of 12.4% between 2020 and 2027.

Figure 2. Global DNA/Gene Microarray Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027

Market Trends/Key Takeaways

DNA microarray is effective and accurate in determining the presence of pathogens in cannabis. According to a November 2019 study results released by PathogenDx, Inc., end-point PCR technologies such as Sequencing and DNA microarray are more accurate in determining the presence of pathogens in cannabis.

Single Nucleotide Polymorphism (SNP) chips have found to give false positive results. According to a study published in the journal bioRxiv in June 2019, SNP chips used by direct-to-consumer genetic testing companies have a false discovery rate of over 85% when screening for very rare variants.

Global DNA/Gene Microarray Market: Competitive Landscape  

Major players operating in the global DNA/gene microarray market include, Affymetrix, Inc., Illumina, Inc., Agilent Technologies Inc., Roche NimbleGen Inc., Sequenom, Inc., Biometrix Technology Inc., LC Sciences, Life Technologies Corp., Lifegen Technologies LLC, Microarrays Inc.

Global DNA/Gene Microarray Market: Key Developments  

Major players in the market are focused on launching new products to expand their product portfolio. For instance, in March 2020, Agilent Technologies Inc. launched Agilent GenetiSure Cyto microarrays for prenatal and postnatal research.

Major players in the market are also focused on adopting collaboration and partnership strategies to enhance their market share. For instance, in July 2019, PathogenDx, Inc. entered into a strategic sales and service distribution partnership with Zef Scientific in Canada.

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.

 What we provide:

·         Customized Market Research Services

·         Industry Analysis Services

·         Business Consulting Services

·         Market Intelligence Services

·         Long term Engagement Model

·         Country Specific Analysis

  Contact Us:

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Email: sales@coherentmarketinsights.com

  Source

https://www.coherentmarketinsights.com/market-insight/dna-gene-microarray-market-3825

[athiranair23]

SNP Genotyping and Analysis Market Analysis (2020-2027)

Single Nucleotide Polymorphism (SNP) represents the most common type of mutation in genomes of all life forms. SNP genotyping is the measurement of genetic variations of SNPs between members of a species.

The global SNP genotyping and analysis market is estimated to account for US$ 11,553.0 Mn in terms of value in 2020 and is expected to reach US$ 46,268.9 Mn by the end of 2027.

Global SNP Genotyping and Analysis Market: Drivers

Increasing prevalence of genetic disorders is expected to propel growth of the global SNP genotyping and analysis market over the forecast period. For instance, according to Summary of the Cystic Fibrosis Foundation Patient Registry, 2003–2018, the number of people with cystic fibrosis increased from 21,421 in 2003 to 30,775 in 2018.

Moreover, collaborative efforts to enhance personalized medicine is also expected to aid in growth of the market. For instance, in April 2020, Indivumed GmbH, an oncology company, launched the Oncology Alliance for Individualized Medicine, an international collaborative alliance to advance personalized medicine in cancer through IndivuType, the company’s multi-omics database.

SNP Microarray held dominant position in the global SNP genotyping and analysis market in 2019, accounting for 37.9% share in terms of value, followed by Taqman Allelic Discrimination and Others, respectively.

Figure 1. Global SNP Genotyping and Analysis Market Share (%), by Value, by Technology, 2019

Global SNP Genotyping and Analysis Market: Restraints

Imperfect protocols leading to large redundant data are expected to hinder growth of the market. Several areas such as diagnostics within the genotyping segment are currently yet to reveal themselves as potential markets. Although diagnostics has been closely associated with SNP genotyping, currently the genotyping technique only serves as a research tool in diagnostics instead of being able to conduct a diagnostic test.

Moreover, despite the high accuracy of short read sequencing, there are still issues with attaining accurate SNP genotypes at low sequencing coverage and in highly duplicated genomes due to misalignment, which is also expected to limit growth of the market.

Global SNP Genotyping and Analysis Market: Opportunities 

Increasing adoption of SNP genotyping in farm animal gene exploration is expected to offer lucrative growth opportunities for players in the global SNP genotyping and analysis market. For instance, in April 2020, researchers from Jung P & C Institute, Inc., South Korea, used Bayesian methods under different genotyping platforms to perform genomic analysis in Korean Duroc pigs.

Moreover, genomic, retrospective, multicenter analysis of cancer is also expected to aid in growth of the market. For instance, in June 2020, a study presented via the virtual Society of Gynecologic Oncology 2020 Annual Meeting on Women's Cancer, reported examining a large clinical dataset of low-grade serous ovarian cancer through the Ovarian Cancer Association Consortium, with the primary goal of identifying factors that affect survival.

The global SNP genotyping and analysis market was valued at US$ 9,485.2 Mn in 2019 and is forecast to reach a value of US$ 46,268.9 Mn by 2027 at a CAGR of 21.9% between 2020 and 2027.

Figure 2. Global SNP Genotyping and Analysis Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027

Market Trends/Key Takeaways

Major players in the market are focused on adopting M&A strategies to expand their product portfolio. For instance, in February 2020, Fluidigm Corporation acquired InstruNor AS, a privately held provider of fully integrated sample preparation system for flow and mass cytometry.

Major players in the market are focused on investing in targeted therapies. For instance, in October 2018, Thermo Fisher Scientific facilitated the next phase of the FinnGen precision medicine study that aims to deepen the overall understanding of chronic disease mechanisms in the Finnish population.

Global SNP Genotyping and Analysis Market: Competitive Landscape

Major players operating in the global SNP genotyping and analysis market include, LGC Limited, Fluidigm Corporation, Illumina, Inc., Life Technologies Corporation, PREMIER Biosoft, Thermo Fisher Scientific, and Sequenom, Inc.

Global SNP Genotyping and Analysis Market: Key Developments

Major players in the market are focused on launching new products to expand their product portfolio. For instance, in July 2019, Thermo Fisher Scientific launched three new Applied Biosystems AgriSeq targeted genotyping by sequencing solutions that will allow customers to genotype canines and felines.

Request sample copy here :  https://www.coherentmarketinsights.com/insight/request-sample/3972

 Request PDF brochure here : https://www.coherentmarketinsights.com/insight/request-pdf/3972

 About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.

What we provide:

·        Customized Market Research Services

·        Industry Analysis Services

·        Business Consulting Services

·        Market Intelligence Services

·        Long term Engagement Model

·        Country Specific Analysis

Contact Us:   

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Email : sales@coherentmarketinsights.com

 Reference/Source: https://www.coherentmarketinsights.com/

[databridgemarketresarch]

Global Genotyping Market – Industry Trends and Forecast to 2024

Market Definition: Global Genotyping Market

Genotyping is a technique of defining genetic make-up differences of an individual by examining the individual’s DNA sequence by means of the biological assays and for comparing it to other individual’s sequence. Genotyping enables researchers to explore genetic variants such as single nucleotide polymorphisms (SNPs) and large structural changes in DNA.

GET SAMPLE REPORT HERE : https://databridgemarketresearch.com/request-a-sample/?dbmr=global-gene-synthesis-market

Gene Synthesis is a synthetic biology method which is used to create artificial genes in a laboratory. It is also known as DNA printing. They are artificial creation of the deoxyribonucleic acid or DNA. It has a crucial role in synthetic biology and biotechnology and also it is an important tool for various fields like vaccine development, molecular engineering, gene therapy, and heterologous gene expression in recombinant DNA technology. They are recently been used to conduct viral research so that they can produce safer and effective DNA vaccines. With gene synthesis it is possible to build variant genes, libraries and even increase the function of protein. It can also be used in designing cancer enzymes and diagnosis of viral genomes for vaccine development.

According to Data Bridge Market Research new Market report, global gene synthesis market will account to an estimated USD 3,542.49 million in 2018 growing at a CAGR of 23.60% during the forecast period of 2019 to 2026.

Segmentation: Global Gene Synthesis Market

Global gene synthesis market is segmented on the basis of products and services, applications, method, end- user and geography. By Products & Services (Consumables, Software, Services Market), Application (Diagnostics, Therapeutics, Research & Developmental Activities, Other Applications), Method (Solid Phase Synthesis, Chip based DNA synthesis, PCR based enzyme synthesis), End-User (Academic & Research Institutes Market, Diagnostic Laboratories Market, Biotech & Pharmaceutical Companies Market, Other Markets), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)

INQUIRE BEFORE BUYING : https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-gene-synthesis-market

Key Market Competitors:

Few of the major competitors currently working in the gene synthesis market are Thermo Fisher Scientific, Inc., Genewiz, Eurofins Scientific, ATD Bio Ltd., OriGene Technologies, Inc., Bioneer Corporation, Atum, Integrated DNA Technologies, Inc., GenScript, Eurogentec, Twist Bioscience., BioCat GmbH, LGC Biosearch Technologies, Eton Bioscience, Inc., Quintara Biosciences, Bio Basic Inc., SBS Genetech Co., Ltd., Merck KGaA among others.

READ MORE

CONTACT US:

Customer Support 24*7

USA Number – +1 888 387 2818 (Toll – Free)

Europe Number – +44 208 089 1725

Asia Pacific Number – +81 34 520 8959

Skype.Address: databridgemarketresearch

Website :https://databridgemarketresearch.com

[reportagestuff]

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Outlook (2018-23): Affymetrix, Agilent Technologies, Illumina and Applied Biosystems

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Outlook (2018-23): Affymetrix, Agilent Technologies, Illumina and Applied Biosystems

Global Single Nucleotide Polymorphism (SNP) Genotyping Market 2018 presents a top to bottom, and expert analysis of the market likewise characterizes the present market inclines, estimate, development rate and order of the business based on Types, Application, Single Nucleotide Polymorphism (SNP) Genotyping key players and critical areas. The Single Nucleotide Polymorphism (SNP) Genotyping report…

[healthcarepharma-blog]

Global Single Nucleotide Polymorphism (SNP) Genotyping Market- Positive Long-Term Growth Outlook 2017-2022

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Single Nucleotide Polymorphism (SNP) Genotyping in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India

 Get Exclusive sample copy @ https://www.researchtrades.com/request-sample/1228806

 Global Single Nucleotide Polymorphism (SNP) Genotyping market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Illumina Affymetrix BGI Beijing Sunbiotech

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Type I Type II

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Single Nucleotide Polymorphism (SNP) Genotyping for each application, including Diagnostics Animal Plant Research Others

Buy a single user copy of this Report For the price of USD 2900 @ https://www.researchtrades.com/checkout/1228806

 Table of Contents 1 Single Nucleotide Polymorphism (SNP) Genotyping Market Overview 1.1 Product Overview and Scope of Single Nucleotide Polymorphism (SNP) Genotyping 1.2 Single Nucleotide Polymorphism (SNP) Genotyping Segment by Type (Product Category) 1.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Segment by Application

2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Competition by Manufacturers 2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Capacity, Production and Share by Manufacturers (2012-2017) 2.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Share by Manufacturers (2012-2017) 2.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Average Price by Manufacturers (2012-2017) 3 Global Single Nucleotide Polymorphism (SNP) Genotyping Capacity, Production, Revenue (Value) by Region (2012-2017) 3.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Capacity and Market Share by Region (2012-2017) 3.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Production and Market Share by Region (2012-2017) 3.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue (Value) and Market Share by Region (2012-2017)

….

Browse This Report @ https://www.researchtrades.com/report/global-single-nucleotide-polymorphism-snp-genotyping-market-research-report-2017/1228806

 Who we are

Research Trades has team of experts who works on providing exhaustive analysis pertaining to market research on a global basis. This comprehensive analysis is obtained by a thorough research and study of the ongoing trends and provides predictive data regarding the future estimations, which can be utilized by various organizations for growth purposes.

 Reach at us:

Email: sales@researchtrades.com

Call us: +1 6269994607 (USA), +91 7507349866 (IND)

Web: http://www.researchtrades.com

Skype ID: researchtradescon.

[ihealthcareanalyst]

Global Single Nucleotide Polymorphism Genotyping Market USD 4.1 Billion by 2020

The global single nucleotide polymorphism genotyping market is estimated to reach USD 4.1 Billion in 2020, growing at a CAGR of 22.3% from 2016 to 2020, according to a market research report Single Nucleotide Polymorphism Genotyping Market 2016-2020, published by iHealthcareAnalyst, Inc.

Visit the Single Nucleotide Polymorphism Genotyping Market 2016-2020 report at https://www.ihealthcareanalyst.com/report/single-nucleotide-polymorphism-genotyping-market/

The global single nucleotide polymorphism genotyping market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).

The global single nucleotide polymorphism genotyping market segmentation is based on technologies (AB SNPlex, MassARRAY MALDI-TOF, SNP by Pyrosequencing, SNP GeneChips and Microarrays, Taqman Allelic Discrimination, and applications (agricultural biotechnology, breeding and animal livestock, diagnostic research, pharmaceuticals and pharmacogenomics).

The global single nucleotide polymorphism genotyping market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. The global single nucleotide polymorphism genotyping market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Technology

AB SNPlex

MassARRAY (MALDI-TOF)

SNP by Pyrosequencing

SNP GeneChips and Microarrays

Taqman Allelic Discrimination

Others

Application

Agricultural Biotechnology

Breeding and Animal Livestock

Diagnostic Research

Pharmaceuticals and Pharmacogenomics

Geography (Region, Country)

North America (U.S., Canada)

Latin America (Brazil, Mexico, Rest of LA)

Europe (U.K., Germany, France, Italy, Spain, Rest of EU)

Asia Pacific (Japan, China, India, Rest of APAC)

Rest of the World

Company Profiles

Affymetrix, Inc.

Douglas Scientific LLC

Fluidigm

Illumina, Inc.

Life Technologies Corporation

PREMIER Biosoft

ThermoFisher Scientific

Sequenom, Inc.

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc. 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043 United States Email: sales@ihealthcareranalyst.com Website: https://www.ihealthcareanalyst.com

- https://www.ihealthcareanalyst.com/global-single-nucleotide-polymorphism-genotyping-market/

[perfectdonutobservation]

Global biochip scanner market

Global biochip scanner market size was US$ XX Bn in 2019 and is expected to reach US$ XX Bn by 2027, at a CAGR of ~18% during the forecast period.

Global Biochip Scanner Market

The report study has analyzed the revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers, and market disrupters in the report, and the same is reflected in our analysis.

Market Definition

Biochips are miniature version of the laboratories and are the most significant part of molecular biology. Biochips are generally used to perform thousands or hundreds of biochemical reactions at the same time. A biochip scanner is a device that is used to discover and obtain fluorescence signal data from biochips or biological microchips and these devices consist of a laser to emit a laser beam and scan the particular rows of the biochips.

Market Dynamics

A biochip scanner market has witnessed an ample growth from the past few years. The growth of the biochip scanner market is primarily driven by its growing significance in various biomedical applications. An increasing requirement to reduce turnaround time, rising demand of biochip scanners for researches and diagnostics activities to perform clinical tests, growing technological advancements and rising applications of biochips, ongoing research and development activities in large-scale genomic and proteomic field and advances in nanotechnology are expected to improve growth of the market during the forecast period.

However, high cost of biochip scanners, risks of hazardous problems of individual privacy and high complexity of biological systems are major restraining factors that could hamper the growth of the market.

Global Biochip Scanner Market: Segmentation Analysis

By type, the DNA chip segment dominated the market in 2019 and is projected to witness fast growth at a CAGR of XX% during the forecast period. Increasing investments in research activities and rising demand for next-generation and advanced genetic disorder diagnosis and detection tools are attributed to the growth of the market. A rising adoption of DNA chips in applications such as gene expression profiling, to identify novel drugs, to discover the dissimilarities in gene expression levels in cells and to detect the mutations in specific genes is expected to improve growth of the market during the forecast period.

Global Biochip Scanner Market: Regional Analysis

Region-wise, North America held the largest market share in 2019 and is expected to maintain its dominance at a CAGR of XX% during the forecast period. The US and Canada are the major key contributors behind the growth of the market. The growth is attributed to the growing technological advancements in the biomedical field across the region.

Growing adoption of biochip scanners in research laboratories and increasing use of biochip scanning technology in drug development, clinical research, toxicology studies, diagnostics and in various clinical trials is driving the growth of the market in the NA region.

The objective of the report is to present a comprehensive analysis of the Global Biochip Scanner Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Biochip Scanner Market dynamics, structure by analyzing the market segments and projects the Global Biochip Scanner Market. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Biochip Scanner Market make the report investor’s guide. The Scope of Global Biochip Scanner Market

Global Biochip Scanner Market, By Type

• DNA Chips • Lab-On-A-Chip • Protein Chips • Cancer Diagnosis and Treatment • Gene Expression • Single Nucleotide Polymorphism (SNP) Genotyping • Genomics • Drug Discovery • Others (Agricultural Biotechnology, Proteomics, Expression Profiling, High Throughput Screening) Global Biochip Scanner Market, By End User

• Biotechnology & Pharmaceutical Companies • Hospitals & Diagnostics Centers • Academic & Research Institutes Global Biochip Scanner Market, By Region

• North America  US  Canada • Europe  UK  France  Germany  Italy  Spain  Norway  Russia • Asia Pacific  China  India  Japan  South Korea  Australia  Malaysia  Indonesia • South America  Brazil  Mexico  Argentina • Middle East and Africa Global Biochip Scanner Market, Key Players

• Agilent Technologies, Inc • Bio-Rad Laboratories, Inc • Cepheid Inc • Fluidigm Corporation • GE Healthcare • Hoffman-La-Roche Ltd • Illumina, Inc • Ocimum Biosolutions Ltd • PerkinElmer, Inc • Takara Bio Inc • Thermo Fisher Scientific Inc • Merck Millipore • Sigma-Aldrich Corporation • Abbott Laboratories • XX • XX For More Information Visit @: https://www.maximizemarketresearch.com/

This Report Is Submitted By :Maximize Market Research Company Customization of the report: Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

About Maximize Market Research: Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors. Contact info: Name: LumawantGodage Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD. Email: sales@maximizemarketresearch.com Address:Pune, Maharashtra 411051, India. Contact: +919607195908

[pankajrathiblog-blog]

Genomics Market in South and Central America - Regional Analysis and Forecast Report by 2027

The South and Central America genomics market is expected to reach US$ 1,263.61 Mn in 2027 from US$ 527.94 Mn in 2018. The market is estimated to grow with a CAGR of 10.4% from 2019-2027.

Request Sample Copy of this Report @ https://www.intelligencemarketresearch.com/ReportEnquiry?ReportID=11201907011204&req_type=sample

The growth of the genomics market is primarily attributed growth in technology developments in genomics rising investments & funds for genomics and development in the field of the agriculture and biotechnology. However, the market is likely to get impacted due to nonexistence of skilled professionals and high cost of equipment used in genomics are likely to pose a negative impact on the market growth. On the other hand, extensive use of genomics for medical applications is likely to have a positive impact on the growth of the South and Central America genomics market in the coming years.

Genomics is the field of science which deals in the production of whole genomes of organisms, and includes elements from genetics. Genomics uses a mixture of recombinant DNA, DNA sequencing methods, and bioinformatics to sequence, assemble, and analyze the structure and function of genomes. The large-scale Genome Centers will present the All of Us genomics platform. The genomics platform comprise achieving up to 200,000 genome-wide assays per year, generating high-quality genotyping and genome sequence data, and contributing to the advancement of technologies for population-scale genome analysis. Moreover, World Health Organization (WHO) to initiate almost US $1 million to launch the special program for research and Training in Tropical Diseases (TDR), which was the first broad genomic initiative involving Latin American countries. Thus, a good investments made by the government, companies is expected to increase the growth of the genomics market over the forecast years.

 In 2018, the microarray segment held the largest market share in the genomics market, by technology. The microarray is expected to dominate its market share in 2027 owing to the microarrays have been widely used as single-nucleotide-polymorphism (SNP) genotyping platforms and the higher acceptance of the microarray in the field of genomics and wider applications. The next generation sequencing (NGS) segment is also anticipated to witness the fastest growth rate during the forecast period, 2019 to 2027.

Ask For Discount @ https://www.intelligencemarketresearch.com/ReportEnquiry?ReportID=11201907011204&req_type=discount

Research centers segment held the largest market share in the genomics market, by end user channel in 2018. This segment is also expected to dominate the market in 2027 owing research centers have developed various technologies in the field of the genomics and research centers provides researchers with references for further researches and this factor is likely to increase the market in the forecast period. Hospitals and clinics segment is also expected to grow at the fastest growth rate during the forecast period, 2019 to 2027.

Some of the major primary and secondary sources for genomic included in the report are Thermo Fisher Scientific Inc., Illumina Inc., Eurofins., Qiagen, Agilent Technologies, BGI, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, QIAGEN, Eurofins Scientific.Novo Nordisk a/s and others.

About Us –

Intelligence Market Research & Consulting, LLP (IMRC) is a global provider of research reports, business intelligence & consulting services. We know and understand the importance of market research data for your institution. Therefore, we have teamed up with the leading research institutes and strategy specialists to bring to you the latest, niche and most relevant statistical research.

Contact Us –

699, Butler St. Suite 1007 Saugatuck, MI - 49453, United States Phone no.- +1 209 691 5657 Email id - sales@intelligencemarketresearch.com Website - www.intelligencemarketresearch.com